Intra-Cellular Therapies Reports Third Quarter 2020 Financial Results and Provides Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. SPCX
2. FDX
3. META
4. ABBV
5. SPY
6. IBM
7. BLZE
8. NKE
9. MU
10. ACN

Go back to Intra-Cellular Therapies Reports Third Quarter 2020 Financial Results and Provides Corporate Update

Intra-Cellular Therapies (ITCI) Tops Q3 EPS by 21c, Revenues Beat

November 9, 2020 7:36 AM EST

Intra-Cellular Therapies (NASDAQ: ITCI) reported Q3 EPS of ($0.79), $0.21 better than the analyst estimate of ($1.00). Revenue for the quarter came in at $7.37 million versus the consensus estimate of $5.86 million.

Our Company is in a strong position. CAPLYTA is approved for the treatment of... More